Cite
HARVARD Citation
Huang, X. et al. (2023). Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combined with anti-angiogenesis therapy: a case report. Anti-cancer drugs. 34 (2), pp. 290-293. [Online].